Vividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer

Press/Media: Research

PeriodFeb 11 2020

Media coverage

11

Media coverage

  • TitleVividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
    Media name/outletGlobal English (Middle East and North Africa Financial Network)
    Country/TerritoryJordan
    Date2/11/20
    PersonsRobert Joseph Abraham
  • TitleVividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
    Media name/outletPR Newswire
    Country/TerritoryUnited States
    Date2/11/20
    PersonsRobert Joseph Abraham
  • TitleVividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
    Media name/outletBioSpace
    Country/TerritoryUnited States
    Date2/11/20
    PersonsRobert Joseph Abraham
  • TitleVividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date2/11/20
    PersonsRobert Joseph Abraham
  • TitleVividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
    Media name/outletProfitQuotes.com
    Country/TerritoryUnited States
    Date2/11/20
    PersonsRobert Joseph Abraham
  • TitleVividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
    Media name/outletTickerTech.com
    Country/TerritoryUnited States
    Date2/11/20
    PersonsRobert Joseph Abraham
  • TitleVividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
    Media name/outletFinanzen.ch
    Country/TerritorySwitzerland
    Date2/11/20
    PersonsRobert Joseph Abraham
  • TitleVividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
    Media name/outletFirstWord Pharma
    Country/TerritoryUnited States
    Date2/11/20
    PersonsRobert Joseph Abraham
  • TitleVividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
    Media name/outletHealthcare Sales & Marketing Network
    Country/TerritoryUnited States
    Date2/11/20
    PersonsRobert Joseph Abraham
  • TitleVividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
    Media name/outletKOTV
    Country/TerritoryUnited States
    Date2/11/20
    PersonsRobert Joseph Abraham
  • TitleVividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
    Media name/outletKPVI
    Country/TerritoryUnited States
    Date2/11/20
    PersonsRobert Joseph Abraham